124 related articles for article (PubMed ID: 38713052)
41. Expression of tight-junction-associated proteins in human gastric cancer: downregulation of claudin-4 correlates with tumor aggressiveness and survival.
Ohtani S; Terashima M; Satoh J; Soeta N; Saze Z; Kashimura S; Ohsuka F; Hoshino Y; Kogure M; Gotoh M
Gastric Cancer; 2009; 12(1):43-51. PubMed ID: 19390931
[TBL] [Abstract][Full Text] [Related]
42. Claudin 19 inhibits the malignant potential of breast cancer cells by modulating extracellular matrix-associated UBE2C/Wnt signaling.
Xu J; Chen M; Hu M; Wang H; Zuo Z; Wang J; Xie Z
Am J Cancer Res; 2022; 12(12):5552-5563. PubMed ID: 36628278
[TBL] [Abstract][Full Text] [Related]
43. MYC, FBXW7 and TP53 copy number variation and expression in gastric cancer.
Calcagno DQ; Freitas VM; Leal MF; de Souza CR; Demachki S; Montenegro R; Assumpção PP; Khayat AS; Smith Mde A; dos Santos AK; Burbano RR
BMC Gastroenterol; 2013 Sep; 13():141. PubMed ID: 24053468
[TBL] [Abstract][Full Text] [Related]
44. Transcriptional activation of the human claudin-18 gene promoter through two AP-1 motifs in PMA-stimulated MKN45 gastric cancer cells.
Yano K; Imaeda T; Niimi T
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G336-43. PubMed ID: 18032479
[TBL] [Abstract][Full Text] [Related]
45. Silencing of claudin-11 is associated with increased invasiveness of gastric cancer cells.
Agarwal R; Mori Y; Cheng Y; Jin Z; Olaru AV; Hamilton JP; David S; Selaru FM; Yang J; Abraham JM; Montgomery E; Morin PJ; Meltzer SJ
PLoS One; 2009 Nov; 4(11):e8002. PubMed ID: 19956721
[TBL] [Abstract][Full Text] [Related]
46. Claudin-1 has tumor suppressive activity and is a direct target of RUNX3 in gastric epithelial cells.
Chang TL; Ito K; Ko TK; Liu Q; Salto-Tellez M; Yeoh KG; Fukamachi H; Ito Y
Gastroenterology; 2010 Jan; 138(1):255-65.e1-3. PubMed ID: 19706291
[TBL] [Abstract][Full Text] [Related]
47. MicroRNA-146-5p promotes proliferation, migration and invasion in lung cancer cells by targeting claudin-12.
Sun X; Cui S; Fu X; Liu C; Wang Z; Liu Y
Cancer Biomark; 2019; 25(1):89-99. PubMed ID: 31006666
[TBL] [Abstract][Full Text] [Related]
48. Expression of tight-junction protein claudin-7 is an early event in gastric tumorigenesis.
Johnson AH; Frierson HF; Zaika A; Powell SM; Roche J; Crowe S; Moskaluk CA; El-Rifai W
Am J Pathol; 2005 Aug; 167(2):577-84. PubMed ID: 16049341
[TBL] [Abstract][Full Text] [Related]
49. Analysis of DNA Damage Response Gene Alterations and Tumor Mutational Burden Across 17,486 Tubular Gastrointestinal Carcinomas: Implications for Therapy.
Parikh AR; He Y; Hong TS; Corcoran RB; Clark JW; Ryan DP; Zou L; Ting DT; Catenacci DV; Chao J; Fakih M; Klempner SJ; Ross JS; Frampton GM; Miller VA; Ali SM; Schrock AB
Oncologist; 2019 Oct; 24(10):1340-1347. PubMed ID: 31040255
[TBL] [Abstract][Full Text] [Related]
50. Increased beta-catenin mRNA levels and mutational alterations of the APC and beta-catenin gene are present in intestinal-type gastric cancer.
Ebert MP; Fei G; Kahmann S; Müller O; Yu J; Sung JJ; Malfertheiner P
Carcinogenesis; 2002 Jan; 23(1):87-91. PubMed ID: 11756228
[TBL] [Abstract][Full Text] [Related]
51. Comprehensive clinical and molecular characterization of claudin 18.2 expression in advanced gastric or gastroesophageal junction cancer.
Kubota Y; Kawazoe A; Mishima S; Nakamura Y; Kotani D; Kuboki Y; Bando H; Kojima T; Doi T; Yoshino T; Kuwata T; Shitara K
ESMO Open; 2023 Feb; 8(1):100762. PubMed ID: 36610262
[TBL] [Abstract][Full Text] [Related]
52. Claudin-1, A Double-Edged Sword in Cancer.
Bhat AA; Syed N; Therachiyil L; Nisar S; Hashem S; Macha MA; Yadav SK; Krishnankutty R; Muralitharan S; Al-Naemi H; Bagga P; Reddy R; Dhawan P; Akobeng A; Uddin S; Frenneaux MP; El-Rifai W; Haris M
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31952355
[TBL] [Abstract][Full Text] [Related]
53. Diagnostic utility of expression of claudins in non-small cell lung cancer: different expression profiles in squamous cell carcinomas and adenocarcinomas.
Jung JH; Jung CK; Choi HJ; Jun KH; Yoo J; Kang SJ; Lee KY
Pathol Res Pract; 2009; 205(6):409-16. PubMed ID: 19231096
[TBL] [Abstract][Full Text] [Related]
54. High Tumor Mutation Burden and Other Immunotherapy Response Predictors in Breast Cancers: Associations and Therapeutic Opportunities.
Voutsadakis IA
Target Oncol; 2020 Feb; 15(1):127-138. PubMed ID: 31741177
[TBL] [Abstract][Full Text] [Related]
55. Claudin 1 differentiates endometrioid and serous papillary endometrial adenocarcinoma.
Sobel G; Németh J; Kiss A; Lotz G; Szabó I; Udvarhelyi N; Schaff Z; Páska C
Gynecol Oncol; 2006 Nov; 103(2):591-8. PubMed ID: 16797678
[TBL] [Abstract][Full Text] [Related]
56. [Еxpression of claudin-1, 3, and 4 in colorectal cancer and polyps].
Nefedova NА; Kharlova ОА; Malkov PG
Arkh Patol; 2016; 78(3):11-19. PubMed ID: 27296001
[TBL] [Abstract][Full Text] [Related]
57. Distinct expression pattern of claudin-6, a primitive phenotypic tight junction molecule, in germ cell tumours and visceral carcinomas.
Ushiku T; Shinozaki-Ushiku A; Maeda D; Morita S; Fukayama M
Histopathology; 2012 Dec; 61(6):1043-56. PubMed ID: 22803571
[TBL] [Abstract][Full Text] [Related]
58. Targeting of claudin-4 by Clostridium perfringens enterotoxin-conjugated polysialic acid nanoparticles for pancreatic cancer therapy.
Shim MK; Na J; Cho IK; Jang EH; Park J; Lee S; Kim JH
J Control Release; 2021 Mar; 331():434-442. PubMed ID: 33508352
[TBL] [Abstract][Full Text] [Related]
59. Prognostic significance of the genetic and the immunohistochemical expression of epithelial-mesenchymal-related markers in colon cancer.
Rashed HE; Hussein S; Mosaad H; Abdelwahab MM; Abdelhamid MI; Mohamed SY; Mohamed AM; Fayed A
Cancer Biomark; 2017 Jul; 20(1):107-122. PubMed ID: 28759954
[TBL] [Abstract][Full Text] [Related]
60. Differential expression of claudin-2 in normal human tissues and gastrointestinal carcinomas.
Aung PP; Mitani Y; Sanada Y; Nakayama H; Matsusaki K; Yasui W
Virchows Arch; 2006 Apr; 448(4):428-34. PubMed ID: 16328347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
